RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 11, 2016

Total Value ($000): $275,445 (100.0% shares, 0.0% debt)

Holdings (34)

ALNY Alnylam Pharmaceuticals Inc 19.7%

Value ($000) $54,383 Shares 866,379 Est. Cost $88.29 Unrealized -24.7%

INCY Incyte Corp 10.0%

Value ($000) $27,496 Shares 379,415 Est. Cost $74.53 Unrealized 0.0%

— La Jolla Pharmaceutical Co 8.9%

Value ($000) $24,445 Shares 1,169,065 Est. Cost $25.02 Unrealized —

— Achillion Pharmaceuticals Inc 7.2%

Value ($000) $19,754 Shares 2,558,859 Est. Cost $10.21 Unrealized —

— Kite Pharma Inc 5.7%

Value ($000) $15,770 Shares 343,503 Est. Cost $58.27 Unrealized —

OMER Omeros Corp 5.0%

Value ($000) $13,676 Shares 891,522 Est. Cost $14.29 Unrealized -14.9%

— Avexis Inc 4.7%

Value ($000) $12,895 Shares 473,374 Est. Cost $27.24 Unrealized —

— Dicerna Pharmaceuticals Inc 3.9%

Value ($000) $10,864 Shares 2,026,894 Est. Cost $13.12 Unrealized —

— Agenus Inc 3.6%

Value ($000) $10,044 Shares 2,414,524 Est. Cost $7.99 Unrealized —

— bluebird bio Inc 3.5%

Value ($000) $9,621 Shares 226,371 Est. Cost $44.12 Unrealized —

— Five Prime Therapeutics Inc 3.3%

Value ($000) $9,223 Shares 226,998 Est. Cost $22.81 Unrealized —

— Mirati Therapeutics Inc 3.3%

Value ($000) $9,169 Shares 428,457 Est. Cost $33.11 Unrealized —

— Symmetry Surgical Inc 3.3%

Value ($000) $9,068 Shares 919,680 Est. Cost $8.83 Unrealized —

— Atara Biotherapeutics Inc. 3.3%

Value ($000) $9,004 Shares 473,126 Est. Cost $25.80 Unrealized —

BMY Bristol-Myers Squibb Co 2.5%

Value ($000) $7,008 Shares 109,701 Est. Cost $45.99 Unrealized -2.6%

BCRX BioCryst Pharmaceuticals Inc 2.0%

Value ($000) $5,586 Shares 1,973,932 Est. Cost $11.05 Unrealized -59.9%

TLT iShares 20+ Year Treasury Bond ETF 1.4%

Value ($000) $3,918 Shares 30,000 Est. Cost $130.60 Unrealized —

— Celldex Therapeutics Inc 1.4%

Value ($000) $3,740 Shares 989,376 Est. Cost $14.34 Unrealized —

— Corium International Inc 1.2%

Value ($000) $3,197 Shares 828,332 Est. Cost $10.40 Unrealized —

— Global Blood Therapeutics Inc 1.1%

Value ($000) $3,029 Shares 190,981 Est. Cost $35.72 Unrealized —

RGNX Regenxbio Inc 0.9%

Value ($000) $2,606 Shares 241,323 Est. Cost $24.07 Unrealized -46.8%

— Lipocine Inc 0.9%

Value ($000) $2,440 Shares 240,438 Est. Cost $6.01 Unrealized —

— Accelerate Diagnostics Inc 0.6%

Value ($000) $1,684 Shares 117,176 Est. Cost $20.90 Unrealized —

— Invuity Inc 0.6%

Value ($000) $1,536 Shares 212,808 Est. Cost $13.10 Unrealized —

— CytRx Corp 0.5%

Value ($000) $1,375 Shares 513,092 Est. Cost $2.73 Unrealized —

MASI Masimo Corp 0.4%

Value ($000) $1,084 Shares 25,900 Est. Cost $40.86 Unrealized -7.9%

— MNKD 01/20/2017 PUT 3 0.3%

Value ($000) $899 Shares 4,385 Est. Cost — Unrealized —

— Biopharmx Corp 0.3%

Value ($000) $764 Shares 700,636 Est. Cost $1.87 Unrealized —

MDRX Allscripts Healthcare Solutions Inc 0.2%

Value ($000) $634 Shares 48,000 Est. Cost $13.76 Unrealized -4.6%

NTRA Natera Inc 0.1%

Value ($000) $302 Shares 31,693 Est. Cost $16.90 Unrealized -49.9%

— Nivalis Therapeutics Inc 0.0%

Value ($000) $125 Shares 30,000 Est. Cost $15.17 Unrealized —

ADAPY Adaptimmune Therapeutics-adr 0.0%

Value ($000) $63 Shares 7,691 Est. Cost $17.51 Unrealized —

— NVRO 05/20/2016 PUT 50 0.0%

Value ($000) $36 Shares 142 Est. Cost — Unrealized —

BRK/B Berkshire Hathaway Inc 0.0%

Value ($000) $7 Shares 50 Est. Cost $134.20 Unrealized -1.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals Inc	866,379	$54,383	19.7%	$88.29	-24.7%	COM	02043Q107
INCY	Incyte Corp	379,415	$27,496	10.0%	$74.53	0.0%	COM	45337C102
—	La Jolla Pharmaceutical Co	1,169,065	$24,445	8.9%	$25.02	—	COM PAR $.0001 2	503459604
—	Achillion Pharmaceuticals Inc	2,558,859	$19,754	7.2%	$10.21	—	COM	00448Q201
—	Kite Pharma Inc	343,503	$15,770	5.7%	$58.27	—	COM	49803L109
OMER	Omeros Corp	891,522	$13,676	5.0%	$14.29	-14.9%	COM	682143102
—	Avexis Inc	473,374	$12,895	4.7%	$27.24	—	COM	05366U100
—	Dicerna Pharmaceuticals Inc	2,026,894	$10,864	3.9%	$13.12	—	COM	253031108
—	Agenus Inc	2,414,524	$10,044	3.6%	$7.99	—	COM NEW	00847G705
—	bluebird bio Inc	226,371	$9,621	3.5%	$44.12	—	COM	09609G100
—	Five Prime Therapeutics Inc	226,998	$9,223	3.3%	$22.81	—	COM	33830X104
—	Mirati Therapeutics Inc	428,457	$9,169	3.3%	$33.11	—	COM	60468T105
—	Symmetry Surgical Inc	919,680	$9,068	3.3%	$8.83	—	COM	87159G100
—	Atara Biotherapeutics Inc.	473,126	$9,004	3.3%	$25.80	—	COM	046513107
BMY	Bristol-Myers Squibb Co	109,701	$7,008	2.5%	$45.99	-2.6%	COM	110122108
BCRX	BioCryst Pharmaceuticals Inc	1,973,932	$5,586	2.0%	$11.05	-59.9%	COM	09058V103
TLT	iShares 20+ Year Treasury Bond ETF	30,000	$3,918	1.4%	$130.60	—	20 YR TR BD ETF	464287432
—	Celldex Therapeutics Inc	989,376	$3,740	1.4%	$14.34	—	COM	15117B103
—	Corium International Inc	828,332	$3,197	1.2%	$10.40	—	COM	21887L107
—	Global Blood Therapeutics Inc	190,981	$3,029	1.1%	$35.72	—	COM	37890U108
RGNX	Regenxbio Inc	241,323	$2,606	0.9%	$24.07	-46.8%	COM	75901B107
—	Lipocine Inc	240,438	$2,440	0.9%	$6.01	—	COM	53630X104
—	Accelerate Diagnostics Inc	117,176	$1,684	0.6%	$20.90	—	COM	00430H102
—	Invuity Inc	212,808	$1,536	0.6%	$13.10	—	COM NEW	46187J205
—	CytRx Corp	513,092	$1,375	0.5%	$2.73	—	COM PAR $.001	232828509
MASI	Masimo Corp	25,900	$1,084	0.4%	$40.86	-7.9%	COM	574795100
—	MNKD 01/20/2017 PUT 3	4,385	$899	0.3%	—	—	Put	56400P201
—	Biopharmx Corp	700,636	$764	0.3%	$1.87	—	COM	09072X101
MDRX	Allscripts Healthcare Solutions Inc	48,000	$634	0.2%	$13.76	-4.6%	COM	01988P108
NTRA	Natera Inc	31,693	$302	0.1%	$16.90	-49.9%	COM	632307104
—	Nivalis Therapeutics Inc	30,000	$125	0.0%	$15.17	—	COM	65481J109
ADAPY	Adaptimmune Therapeutics-adr	7,691	$63	0.0%	$17.51	—	SPONDS ADR	00653A107
—	NVRO 05/20/2016 PUT 50	142	$36	0.0%	—	—	Put	64157F103
BRK/B	Berkshire Hathaway Inc	50	$7	0.0%	$134.20	-1.2%	CL B NEW	084670702